Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
Holding LYEL?
Track your performance easily

Lyell Immunopharma (LYEL) Ownership - Who Owns Lyell Immunopharma?

89 Followers

Lyell Immunopharma (LYEL) Ownership Overview

18.05%10.41%0.24%7.93%63.38%
18.05% Insiders
0.24% Other Institutional Investors
7.93% ETFs
63.38% Public Companies and
Individual Investors
The ownership structure of Lyell Immunopharma (LYEL) stock is a mix of institutional, retail, and individual investors. Approximately 18.58% of the company’s stock is owned by Institutional Investors, 18.05% is owned by Insiders, and 63.38% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
36,477,716Insider14.50%45,232,368
11,806,630Institution4.61%14,640,221
9,617,979Institution3.76%11,926,294
8,241,302Institution3.22%10,219,214
5,921,942Institution2.31%7,343,208
4,685,614Insider1.83%5,810,161
3,653,199Insider1.43%4,529,967
1,872,361Institution0.73%2,321,728
1,699,230Institution0.66%2,107,045
1,147,315Institution0.45%1,422,671

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
11,806,630Institution4.61%14,640,221
5,921,942Institution2.31%7,343,208
1,872,361Institution0.73%2,321,728
1,699,230Institution0.66%2,107,045
1,147,315Institution0.45%1,422,671
942,414Institution0.37%1,168,593
767,436Institution0.30%951,621
441,172Institution0.17%547,053
419,906Institution0.16%520,683
286,014Institution0.11%354,657

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,817,818Institution2.27%8,028,589
4,276,756Institution1.67%5,431,480
2,522,865Institution0.99%3,481,554
1,557,069Institution0.61%1,977,478
737,066Institution0.29%1,017,151
795,386Institution0.31%1,010,140
768,543Institution0.30%860,768
418,655Institution0.16%577,744
364,118Institution0.14%462,430
343,195Institution0.13%435,858

FAQ

Who Owns Lyell Immunopharma (LYEL)?
According to the latest TipRanks data, approximately 0.24% of the company's stock is held by institutional investors, 18.05% is held by insiders, and 63.38% is held by retail investors.
    What percentage of Lyell Immunopharma (LYEL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.24% of Lyell Immunopharma (LYEL) stock is held by institutional investors.
      What percentage of Lyell Immunopharma (LYEL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 63.38% of Lyell Immunopharma (LYEL) stock is held by retail investors.
        Who owns the most shares of Lyell Immunopharma (LYEL)?
        Robert Nelsen owns the most shares of Lyell Immunopharma (LYEL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis